mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |